Effect of Soy Protein and Colorado Diet on Weight Loss and Maintenance

October 3, 2019 updated by: DuPont Nutrition and Health

The Effect of Incorporating Soy Protein Foods in the Colorado Diet for Weight Loss and Maintenance

Dietary protein is a key element of most effective weight loss regimens. This study will investigate the effects of consuming soy protein on body composition and cardiometabolic health within the context of an effective weight loss and maintenance program called the Colorado Diet.

Study Overview

Detailed Description

This is a randomized study comparing the efficacy of inducing weight loss of two treatment arms all based on the Colorado Diet. Subjects will be randomly assigned to one of two study arms and instructed to follow the Colorado Diet by participating in weekly State of Slim group classes. Subjects will be followed in the study for one year. The Colorado Diet consists of 3 phases: phase 1 (week 1-2), phase 2 (weeks 3 - 8), and phase 3 (weeks 9 - 16). The maintenance phase lasts from months 5 - 12. Body weight will be monitored at each study visit and body composition will be determined using DXA. Blood lipid and lipoprotein concentrations, health & wellness questionnaires, and fitness measures will also be assessed throughout the study.

Study Type

Interventional

Enrollment (Anticipated)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • Anschutz Health and Wellness Center, University of Colorado

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI between 27-40
  • Weight stable (have not lost or gained more than 10 pounds in the last 3 months)
  • Generally healthy
  • Able to exercise 70 minutes per day at moderate intensity
  • Willing and able to participate in a State of Slim group class for the first 16 weeks of the study and willing to participate in 5 study visits over the 12 month study period.

Exclusion Criteria:

  • Pregnant or trying to become pregnant.
  • Diagnosis of type 1 or type 2 diabetes
  • Individuals following a vegetarian only diet
  • Food allergies (to soy, dairy, wheat/gluten, or peanut)
  • Taking medications that could cause weight loss or weight gain or alter plasma lipids (such as steroids, tricyclic antidepressants, chemotherapy, antipsychotics, prescribed or OTC weight loss agents, statins, fibrates, niacin, etc). Oral contraceptives can be used as long as subject agrees to not change use of these during the study.
  • Known renal disease
  • Clinical hypothyroidism
  • Current alcohol or drug abuse or dependence (Subjects who have quit smoking in the last 6 months will be excluded. Smokers whose smoking habits have been stable for the last 6 months and which remain stable during the study can be included).
  • Any medical condition for which following a diet and/or 70 minutes of exercise daily would be inadvisable
  • LDL cholesterol levels above 190 mg/dl or triglycerides above 400 mg/dl.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Colorado Diet with soy protein

Phase 1 (week 1-2): Participants will be given soy protein powder and asked to consume 3 protein shakes per day.

Phase 2 (week 3-8): Participants will be given both protein powder and soy patties designed to be similar to other phase 2 acceptable foods and will be asked to consume 2 soy protein shakes and 1 soy patty per day.

Phase 3 (week 9-16): Participants will be given protein powder, soy patties, and protein bars designed to be similar to other phase 3 acceptable foods and will be asked to consume 1 soy protein shake, 1 soy patty and 1 soy protein bar per day.

Maintenance Phase (month 5-12): Participants will continue to receive study food products (protein powder, patties and protein bars)

Active Comparator: Colorado Diet

Phase 1 (week 1-2): Participants will be given monetary stipend and asked to consume 3 non-soy protein shakes per day.

Phase 2 (week 3-8): Participants will be given monetary stipends and asked to consume 2 non-soy protein shakes per day.

Phase 3 (week 9-16): Participants will be given monetary stipend and asked to consume 1 non-soy protein shake and 1 non-soy protein bar per day.

Maintenance Phase (month 5-12): Participants will continue to receive monetary stipend.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body weight & body composition
Time Frame: 0, 2, 4, 8, 12 mths
Changes in skeletal muscle mass and fat mass will be measured using dual-energy X-ray absorptiometry (DXA)
0, 2, 4, 8, 12 mths

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood lipid and lipoproteins
Time Frame: 0, 2, 4, 8, 12 mths
Changes in lipids and lipoproteins will be measured using the Vertical Auto Profile (VAP) Test
0, 2, 4, 8, 12 mths
C-reactive protein
Time Frame: 0, 2, 4, 8, 12 mths
Changes in inflammatory status will be assessed by measuring circulating c-reactive protein
0, 2, 4, 8, 12 mths
Level of Fitness
Time Frame: 0, 12 mths
Changes in the level of fitness will be measured by a 3 minute step test, grip strength, and flexibility testing.
0, 12 mths
Quality of Life
Time Frame: 0, 4, 8, 12 mths
Changes in the quality of life will be measured via Wellness Assessment Questionnaire
0, 4, 8, 12 mths

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: James O Hill, PhD, University of Colorado, Denver

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2015

Primary Completion (Actual)

October 1, 2016

Study Completion (Actual)

November 1, 2016

Study Registration Dates

First Submitted

February 23, 2015

First Submitted That Met QC Criteria

March 1, 2015

First Posted (Estimate)

March 5, 2015

Study Record Updates

Last Update Posted (Actual)

October 4, 2019

Last Update Submitted That Met QC Criteria

October 3, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1152341

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Colorado Diet with soy protein foods.

Subscribe